EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides

Jacopo Millul, Lennart Koepke, Gaonkar Raghuvir Haridas, Konstantin M J Sparrer, Rosalba Mansi, Melpomeni Fani iD

European Journal of Nuclear Medicine and Molecular Imaging · 2023

DOI: 10.1007/s00259-023-06272-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Jacopo Millul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Albumins, Peptides. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Fibroblast activation protein-α (FAP)-targeting radioligands have recently demonstrated high diagnostic potential. However, their therapeutic value is impaired by the short tumor residence time. Several strategies have been tested to overcome this limitation, but a head-to-head comparison has never been done. With the aim to identify strengths and limitations of the suggested strategies, we compared the monomer FAPI-46 versus (a) its dimer (FAPI-46-F1D), (b) two albumin binders conjugates (FAPI-46-Ibu (ibuprofen) and FAPI-46-EB (Evans Blue)), and (c) cyclic peptide FAP-2286.

Methods

177 Lu-labeled ligands were evaluated in vitro in cell lines with low (HT-1080.hFAP) and high (HEK-293.hFAP) humanFAP expression. SPECT/CT imaging and biodistribution studies were conducted in HT-1080.hFAP and HEK-293.hFAP xenografts. The areas under the curve (AUC) of the tumor uptake and tumor-to-critical-organs ratios and the absorbed doses were estimated.

Results

Radioligands showed IC 50 in the picomolar range. Striking differences were observed in vivo regarding tumor uptake, residence, specificity, and total body distribution. All [ 177 Lu]Lu-FAPI-46-based radioligands showed similar uptake between the two tumor models. [ 177 Lu]Lu-FAP-2286 showed higher uptake in HEK-293.hFAP and the least background. The AUC of the tumor uptake and absorbed dose was higher for [ 177 Lu]Lu-FAPI-46-F1D and the two albumin binder conjugates, [ 177 Lu]Lu-FAPI-46-Ibu and [ 177 Lu]Lu-FAPI-46-EB, in HT1080.hFAP xenografts and for [ 177 Lu]Lu-FAPI-46-EB and [ 177 Lu]Lu-FAP-2286 in HEK293.hFAP xenografts. The tumor-to-critical-organs AUC values and the absorbed doses were in favor of [ 177 Lu]Lu-FAP-2286, but tumor-to-kidneys.

Conclusion

The study indicated dimerization and cyclic peptide structures as promising strategies for prolonging tumor residence time, sparing healthy tissues. Albumin binding strategy outcome depended on the albumin binding moiety. The peptide showed advantages in terms of tumor-to-background ratios, besides tumor-to-kidneys, but its tumor uptake was FAP expression–dependent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuminsPeptidesHumansHEK293 CellsTissue DistributionCell Line, TumorPeptides, CyclicPositron Emission Tomography Computed TomographyGallium RadioisotopesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

Albumin binderDimerFAP-2286FAPIFibroblast activation protein-α (FAP)Radioligand therapy

Substanzen

AlbuminsPeptidesPeptides, CyclicGallium RadioisotopesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland.
  • Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
  • Division of Radiopharmaceutical Chemistry, University Hospital Basel, Basel, Switzerland. melpomeni.fani@usb.ch.

ORCID-Profile: Melpomeni Fani

Förderung

  • University of Basel

Zitieren

APA

Millul, J., Koepke, L., Haridas, G. R., Sparrer, K. M. J., Mansi, R., & Fani, M. (2023). Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06272-7

Vancouver

Millul J, Koepke L, Haridas GR, Sparrer KMJ, Mansi R, Fani M. Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06272-7

BibTeX
@article{Millul2023,
  author = {Millul, Jacopo and Koepke, Lennart and Haridas, Gaonkar Raghuvir and Sparrer, Konstantin M J and Mansi, Rosalba and Fani, Melpomeni},
  title = {Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  doi = {10.1007/s00259-023-06272-7}
}
Kostenlos starten →